References
1. Biscardi, S., Lorrot, M., Marc, E., et al. Mycoplasma pneumoniae and asthma in children. Clinical Infectious Diseases 38.10 (2004): 1341-1346 2. Centers for Disease Control and Prevention: National Center for Immunization and Respiratory Diseases, Division of Bacterial Disease. Mycoplasma pneumoniae Infection: History and Disease (2016) 3. Broulette, J, Yu, H, Pyenson, B, et al. The Incidence Rate and Economic Burden of Community-Acquired Pneumonia in a Working-Age Population. Am Health Drug Benefits (2013): 6(8): 494-503. 4. Waites, K.B., Mitchell F.B., and Atkinson, T.P. New insights into the pathogenesis and detection of Mycoplasma pneumoniae infections. Future Microbiology (2008): 635-648. 5. Waites, K.B., Talkington, D.F. Mycoplasma pneumoniae and Its Role as a Human Pathogen. Clinical Microbiology Reviews (2004): 697-728. 6. Nilsson, A.C., Björkman, P., and Persson, K.. Polymerase chain reaction is superior to serology for the diagnosis of acute Mycoplasma pneumoniae infection and reveals a high rate of persistent infection. BMC Microbiology 8.1 (2008): 93. 7. Graffelman, A. W., Willemssen, F. E., Zonderland, H. M., et al. Limited value of chest radiography in predicting aetiology of lower respiratory tract infection in general practice. The British Journal of General Practice, 58.547 (2008): 93–97. 8. illumigene® Mycoplasma Direct Package Insert, SN11194. |